ICON9 Trial

Collection of samples and data across the following diseases: Malignant tumour of ovary An international phase III randomised study to evaluate the efficacy of maintenance cediranib and olaparib combination therapy or olaparib alone in patients with relapsed platinum-sensitive ovarian cancer following a response to platinum-based chemotherapy

Webpage:
https://www.healthdatagateway.org/dataset/097cc6bd-ce98-47ec-a73d-5d2c250f2697

Licence:
Name: HDR UK Innovation Gateway Access
URL: https://www.hdruk.ac.uk/infrastructure/gateway/terms-and-conditions/

Tags:

icon9 olaparib cediranib malignant tumour of ovary cancer ovarian

More to explore:

1/20



Need help integrating and/or managing biomedical data?